Therma Bright Inc (THRM) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.026x

Based on the latest financial reports, Therma Bright Inc (THRM) has a cash flow conversion efficiency ratio of 0.026x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.76K ≈ $-28.04K USD) by net assets (CA$-1.52 Million ≈ $-1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See THRM equity to assets ratio to measure how much of total assets are equity-financed.

Therma Bright Inc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Therma Bright Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check THRM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Therma Bright Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Therma Bright Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Proven Vct PLC
LSE:PVN
-0.007x
Ace Integrated Solutions Limited
NSE:ACEINTEG
0.021x
Keystone Law Group PLC
LSE:KEYS
0.375x
Orion Equities Ltd
AU:OEQ
-0.017x
MOBILUM TECHNOLOGIES INC.
F:C0B
N/A
Fountain Asset Corp
V:FA
0.119x
Nexity Global SA
WAR:NXG
-0.001x
Nextferm Technologies Ltd
TA:NXFR
N/A

Annual Cash Flow Conversion Efficiency for Therma Bright Inc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Therma Bright Inc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see THRM stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-07-31 CA$-1.57 Million
≈ $-1.13 Million
CA$-146.53K
≈ $-106.00K
0.094x +112.28%
2024-07-31 CA$1.32 Million
≈ $958.00K
CA$-1.01 Million
≈ $-730.10K
-0.762x +98.43%
2023-07-31 CA$44.79K
≈ $32.40K
CA$-2.17 Million
≈ $-1.57 Million
-48.555x -3410.13%
2022-07-31 CA$2.75 Million
≈ $1.99 Million
CA$-3.80 Million
≈ $-2.75 Million
-1.383x +36.29%
2021-07-31 CA$1.32 Million
≈ $951.41K
CA$-2.86 Million
≈ $-2.07 Million
-2.171x -363.35%
2020-07-31 CA$223.97K
≈ $162.01K
CA$-104.94K
≈ $-75.91K
-0.469x -170.73%
2019-07-31 CA$-286.40K
≈ $-207.18K
CA$-189.72K
≈ $-137.24K
0.662x -86.82%
2018-07-31 CA$-71.59K
≈ $-51.79K
CA$-359.89K
≈ $-260.34K
5.027x +2417.45%
2017-07-31 CA$-893.85K
≈ $-646.59K
CA$-178.49K
≈ $-129.11K
0.200x +601500.19%
2016-07-31 CA$-1.63 Million
≈ $-1.18 Million
CA$54.00
≈ $39.06
0.000x -100.22%
2015-07-31 CA$-1.42 Million
≈ $-1.03 Million
CA$-21.43K
≈ $-15.50K
0.015x +50.83%
2014-07-31 CA$-5.52 Million
≈ $-3.99 Million
CA$-55.16K
≈ $-39.90K
0.010x -33.21%
2013-07-31 CA$-5.62 Million
≈ $-4.06 Million
CA$-84.10K
≈ $-60.84K
0.015x +22658.84%
2012-07-31 CA$-6.61 Million
≈ $-4.78 Million
CA$-435.00
≈ $-314.67
0.000x -97.60%
2011-07-31 CA$-5.83 Million
≈ $-4.22 Million
CA$-16.00K
≈ $-11.57K
0.003x -78.02%
2009-07-31 CA$-5.03 Million
≈ $-3.64 Million
CA$-62.68K
≈ $-45.34K
0.012x -87.91%
2008-07-31 CA$-3.54 Million
≈ $-2.56 Million
CA$-365.58K
≈ $-264.45K
0.103x -61.80%
2007-07-31 CA$-2.00 Million
≈ $-1.44 Million
CA$-539.12K
≈ $-389.99K
0.270x -69.93%
2006-07-31 CA$-1.46 Million
≈ $-1.06 Million
CA$-1.31 Million
≈ $-950.53K
0.898x +73.98%
2005-07-31 CA$-991.06K
≈ $-716.92K
CA$-511.69K
≈ $-370.15K
0.516x -95.60%
2004-07-31 CA$-117.47K
≈ $-84.98K
CA$-1.38 Million
≈ $-997.57K
11.739x +2050.43%
2002-07-31 CA$1.61 Million
≈ $1.16 Million
CA$-968.11K
≈ $-700.31K
-0.602x +22.24%
2001-07-31 CA$633.46K
≈ $458.24K
CA$-490.32K
≈ $-354.69K
-0.774x --

About Therma Bright Inc

V:THRM Canada Medical Devices
Market Cap
$2.10 Million
CA$2.90 Million CAD
Market Cap Rank
#29934 Global
#1476 in Canada
Share Price
CA$0.05
Change (1 day)
+0.00%
52-Week Range
CA$0.05 - CA$0.11
All Time High
CA$0.87
About

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical he… Read more